DR. ROBERT M. WORTH, M.D.

Plain English
This study looked at how Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) develops after someone has infectious mononucleosis, which is often caused by the Epstein-Barr virus. The researchers followed a group of college students for seven years and found that 81% of those who had severe ME/CFS initially still had the condition after seven years, while only about one-third of those with moderate symptoms remained affected. This matters because it highlights that severe cases of ME/CFS can last a long time, which is important for understanding how to support patients and manage the illness. Who this helps: This helps patients dealing with ME/CFS and their healthcare providers.

Plain English
This study looked at whether adding a treatment called transcutaneous electrical nerve stimulation (TENS) to regular physical therapy could help reduce pain during movement in people with fibromyalgia. They found that participants using TENS reported a 1.2-point decrease in pain on a scale of 0 to 10 compared to those who only received physical therapy. Additionally, 72% of those using TENS felt a positive change in their condition, highlighting TENS as a safe and affordable option for managing fibromyalgia pain. Who this helps: Patients with fibromyalgia benefit from this treatment.

Plain English
This study focused on pneumonia, a common and serious lung infection that often leads to hospitalization and can be deadly, especially among older patients or those with other health issues. Researchers found that pneumonia can be classified into three types—community-acquired, hospital-acquired, and pneumonia in severely immunocompromised patients—and each type requires different treatments and diagnoses. Effective management and follow-up care after recovering from pneumonia are crucial to improving patient outcomes and reducing complications. Who this helps: This helps patients, especially older adults and those with other health conditions.

Plain English
This study looks at how platelets, which are known for helping blood clot, also play an important role in managing inflammation by working with immune cells called neutrophils. Researchers found that platelets can influence how neutrophils die, which is crucial for resolving inflammation in the body. This is important because better understanding these interactions could lead to new treatments for diseases caused by inflammation. Who this helps: This helps patients suffering from inflammatory diseases.

Plain English
This study focused on how certain changes (mutations) in the HIV protease enzyme affect how well anti-HIV drugs can bind to it. The researchers found that a specific mutation made the protease more flexible, which made it harder for drugs to attach, leading to decreased drug effectiveness. Additionally, some background mutations helped stabilize the enzyme but still didn’t fully restore its ability to bind the drugs effectively. Who this helps: This helps doctors understand HIV drug resistance better, leading to more effective treatments for patients.

Plain English
This study looked at how a private physical therapy practice implemented a system that allows physical therapists to directly refer patients for X-rays without needing an imaging department. They found that, after the new process was set up, patients received their X-ray referrals in just 15 minutes and the results were returned within 30 minutes, allowing efficient and effective care. This matters because it helps streamline patient diagnostics and treatment, ensuring that physical therapists can make quicker clinical decisions. Who this helps: Patients who need quick imaging for their treatment benefit from this system.

Plain English
This study focused on how certain chloride proteins (CLIC1 and CLIC4) enter the nucleus of cells, which is important for their function. Researchers found that a specific sequence in CLIC4 helps it bind to a protein that assists in its nuclear import; they noted that changes to this sequence can prevent nuclear entry, which is linked to a type of skin cancer. Understanding this process is crucial because it could lead to new insights on cancer mechanisms and potential treatments. Who this helps: This helps patients with skin cancer and researchers trying to develop targeted therapies.

Plain English
This paper examines the connection between autism spectrum disorder (ASD) and epilepsy, noting that nearly half of individuals with ASD also have epilepsy. The researchers found that both conditions may share similar issues in the brain's functioning, but it’s still unclear if one causes the other. Understanding these similarities is important because it can lead to better treatments and support for people facing both diagnoses. Who this helps: This helps patients with autism and epilepsy, as well as their families and healthcare providers.

Plain English
This study developed a new method to measure how strongly antibodies bind to proteins in complex biological samples, like blood. Using this method, researchers analyzed how existing antibodies in people who had not been exposed to the Omicron variant of SARS-CoV-2 responded to various strains of the virus. This new approach can provide detailed information about the strength and amount of antibodies present, which is crucial for understanding immune responses and developing vaccines. Who this helps: This research benefits patients and vaccine developers.

Plain English
This study examined a variant of the HIV-1 protease that had two extra amino acids added at a specific location. They found that this variant was about 50% less active than the typical protease, but it was also more stable at higher temperatures, suggesting it could help the virus resist treatments. These findings are important because understanding how changes in the protease affect its function can inform the development of more effective HIV treatments. Who this helps: This helps patients with HIV by informing better treatment strategies.

Plain English
This study looked at how the flexibility of the HIV protease enzyme affects its ability to bind with drugs designed to inhibit it. Researchers found that when the virus develops mutations, especially secondary ones, it can make drugs less effective by either increasing the difficulty of closing the enzyme or making it easier for the drug to break away from its target. Understanding how this elasticity impacts drug resistance is important because it could lead to better drug designs for fighting HIV. Who this helps: This helps patients with HIV by potentially leading to more effective treatments.

Plain English
This study looked at how and where people with intellectual disabilities (IDs) died while living in group homes in Australasia. Researchers examined 66 deaths over two years and found that while death is relatively rare in these settings, most occurrences happened in hospitals, regardless of the cause of death. Understanding these patterns is important because it helps improve care and support for individuals in community settings as they approach the end of life. Who this helps: This benefits patients with intellectual disabilities and their caregivers.

Plain English
This study looked at how people with intellectual disabilities in the UK die and whether those deaths were expected or unexpected. Out of 149 deaths investigated, only 34.2% were anticipated, meaning that most deaths either happened suddenly or followed a brief illness. The findings highlight the need for better support and preparation for families and caregivers when facing these unanticipated deaths. Who this helps: This helps patients, families, and care providers working with individuals with intellectual disabilities.

Plain English
This study examined how certain mutations in the HIV-1 protease enzyme affect its behavior when treated with antiviral drugs. Researchers found that mutations in two variants of the protease, HP3 and HP4, made the enzyme more dynamic and likely to adopt a semi-open shape, which reduced the binding strength of three key drugs (saquinavir, atazanavir, and darunavir). This is important because it helps explain how the virus can resist medications, making treatment less effective. Who this helps: This research benefits patients with HIV by providing insights for better treatment strategies.

Plain English
This study looked at adults with intellectual disabilities living in care homes in the UK to understand their end-of-life care needs and mortality rates. Researchers gathered information on 132 residents, finding that after one year, 18% had died, with an average age at death of 72.2 years. This is important because it highlights the need for better end-of-life care for this group, as a significant number may need additional support in their final months. Who this helps: Patients with intellectual disabilities and their caregivers.

Plain English
This study looked at the end-of-life care experiences of adults with intellectual disabilities (ID) living in residential care in the UK. Researchers found that many of these individuals had complex health needs and that a significant number (about 70%) of the reported deaths were unexpected. While the general care in facilities was rated positively, hospital care and the awareness of approaching death were not as good compared to the general population, highlighting a need for better support and involvement of individuals with ID in their end-of-life planning. Who this helps: This helps patients with intellectual disabilities and their caregivers.

Plain English
Researchers studied how the brain connects different ideas and understands their relationships by using brain scans while people listened to stories. They found that related concepts activate overlapping areas in the brain rather than separate regions, showing that our brain uses interconnected networks for understanding both specific ideas and how they relate. This matters because it helps us understand how we think and process complex information, particularly how we move from concrete ideas to more abstract ones. Who this helps: This helps patients with cognitive impairments and doctors who treat them.

Plain English
This study focused on improving the way HIV protease, an important enzyme for HIV treatment, is extracted from bacterial cells where it often ends up in clumps that are not usable. Researchers developed a two-step method that successfully recovered, refolded, and purified the enzyme to be highly pure and active, producing the HIV protease in functional form. This is significant because having pure and active HIV protease is essential for studying the enzyme's structure and for the development of effective HIV medications. Who this helps: This benefits researchers and doctors developing HIV treatments.

Plain English
This study examined how people with intellectual disabilities die, based on data from service providers in the UK who support over 12,000 individuals. Out of 222 deaths analyzed, only about 34% were expected by care staff, and the overall death rate was 12.2 per 1,000 people each year. The findings highlight that many individuals with intellectual disabilities experience unanticipated deaths, particularly those living in supported settings, leading to poorer outcomes in their final days. Who this helps: This helps patients and families, as well as caregivers and healthcare providers who support individuals with intellectual disabilities.

Plain English
This study looked at how ellagic acid (EA) can block a specific enzyme in the Schistosoma japonicum parasite, which helps it detoxify harmful substances. Researchers found that EA reduced the enzyme's activity by 66% when tested in the lab, with a specific concentration needed for this effect being 2.4 micromolar. Understanding how EA interacts with this enzyme could lead to new treatments for schistosomiasis, a disease caused by this parasite. Who this helps: This research benefits patients suffering from schistosomiasis by potentially leading to more effective treatments.

Plain English
This research paper looks at how physical factors, like the stiffness and texture of materials used in medical treatments, affect the behavior of immune cells called macrophages. The findings show that different types of mechanical stress can change how these cells act, which is crucial in managing inflammation and healing tissues. Understanding these changes can lead to better designs for tissue regeneration treatments, improving recovery for patients with injuries or surgical needs. Who this helps: Patients undergoing tissue repair or regeneration treatments.

Plain English
This paper discusses how physical forces can influence the behavior of immune cells called macrophages. It found that when these cells experience mechanical changes, they respond by altering their activity and how they function in the immune system, although specific numbers were not reported in this correction. This is important because understanding these changes can lead to better treatments for various diseases by targeting how immune cells respond to their environment. Who this helps: This helps patients with immune-related conditions.

Plain English
This study examined how nurses provide care for people with intellectual disabilities during their final months of life in the UK. Researchers surveyed 38 care providers and found that most deaths occurred between ages 50 and 69, with respiratory problems being the leading cause. While nursing care was generally seen as positive, there is a need for better training to improve support for these individuals. Who this helps: This benefits patients with intellectual disabilities and the nurses who care for them.

Plain English
This study looked at the effectiveness and safety of a treatment called deep brain stimulation in the thalamus for people with epilepsy that doesn’t respond to medications. After one year of treatment, patients saw a 41% decrease in their seizures, which improved to a 69% reduction by the fifth year. More than half of the participants reported having fewer seizures, and 16% were seizure-free for at least six months, with no unexpected serious side effects reported. Who this helps: This benefits patients with drug-resistant partial epilepsy who are looking for alternative treatment options.

Plain English
This research focused on developing a new method to predict seizures in people with epilepsy using a special algorithm that processes signals from the brain. The algorithm can predict seizures about 6.7 seconds before they happen with 92% accuracy and very few false alarms—0.08 per minute—making it more reliable for real-time use. This is important because it could lead to better treatment options for the 30% of epilepsy patients who have seizures that current medications can't control. Who this helps: This benefits patients with epilepsy, particularly those who experience difficult-to-treat seizures.

Plain English
This study looked at using electrical stimulation in a part of the brain called the anterior nucleus of the thalamus to treat patients with epilepsy who didn't respond to medication. Researchers found that participants who received stimulation had a 29% greater reduction in their seizures compared to those who did not get the treatment during the first three months; over two years, the overall reduction in seizure frequency was 56%, with more than half of the patients experiencing at least a 50% decrease in seizures. This matters because it offers a new option for patients struggling to manage their epilepsy with current medications. Who this helps: Patients with epilepsy who have not had success with drug treatments.

Plain English
This study looked at how levels of Troponin T, which indicates heart damage, can predict health problems in older patients having surgery for a hip fracture. Among 108 patients studied, 39% had elevated Troponin levels, and those with higher levels were much more likely to experience complications, such as heart issues, and had longer hospital stays—averaging about 26 days compared to 18 days for those without elevated Troponin. Additionally, there were more deaths in the group with elevated levels, highlighting the serious risks associated with undetected heart problems in these patients. Who this helps: This helps older patients undergoing hip fracture surgery by identifying those at greater risk for complications.

Plain English
This study looked at using electrical stimulation to help people with epilepsy that doesn't respond to typical medications. Researchers found that stimulating specific brain areas, like the thalamus and hippocampus, can reduce the number of seizures in some patients. For example, early results show promise for techniques that detect and interrupt seizures before they happen. Who this helps: This helps patients with refractory epilepsy who struggle with frequent seizures.

Plain English
This study looked at umbilical cord ruptures, which can happen before or during delivery and can be very dangerous for the baby. The researchers found that these ruptures are more common than reported and highlight the need for better prediction methods to reduce the risk of serious outcomes, like death. By identifying these risks, healthcare providers can take quicker action to protect unborn babies. Who this helps: Expecting parents and healthcare providers.

Plain English
Researchers studied the outcomes of surgery for temporal lobe epilepsy (TLE) in 262 patients, focusing on those who continued having seizures after the operation and the role of reoperation. They found that 65% of patients were completely seizure-free after surgery, while 16% faced ongoing seizures. Among those needing reoperation, 57% became seizure-free afterward, indicating that patients with specific brain activity patterns had better outcomes if they underwent further surgery. Who this helps: This helps patients with temporal lobe epilepsy who are struggling to control their seizures after initial surgery.

Plain English
This study focused on improving the diagnosis of aneurysmal subarachnoid hemorrhage, a serious condition that can lead to death in 32% to 67% of cases if left untreated. It found that a CT scan done within 12 hours can accurately detect the hemorrhage 98% of the time, and if the scan is negative after 12 hours, a special test on spinal fluid can still identify it with 96% accuracy for up to two weeks. These findings are important because they can help ensure timely and correct diagnosis, which is crucial for effective treatment and improving patient outcomes. Who this helps: This helps doctors and their patients at risk of subarachnoid hemorrhage.

Plain English
This study looked at patients with temporal lobe epilepsy (TLE) to find out how many had dual conditions affecting their brains and how this impacted their treatment outcomes. Among 240 patients, 37 (15.4%) had dual pathology, meaning they had another brain issue alongside hippocampal sclerosis. After surgery, 70.2% of these patients no longer had seizures, indicating that surgeries targeting both the damaged area and surrounding tissue can be very effective. Who this helps: This benefits patients suffering from temporal lobe epilepsy, particularly those with multiple brain issues.

Plain English
This study looked at how a specific type of X-ray, called a schuss radiograph, affects treatment decisions for patients with knee osteoarthritis. The researchers found that when doctors used schuss X-rays instead of standard X-rays, they changed their treatment plans in over 40% of the cases, leading to nearly a 50% reduction in unnecessary knee surgeries. This matters because using schuss radiographs can help doctors make better decisions and avoid unnecessary operations, which can improve patient care and reduce healthcare costs. Who this helps: Patients with knee osteoarthritis.

Plain English
This study looked at the results of surgery for patients with hard-to-treat temporal lobe epilepsy (TLE) involving 215 patients. After surgery, 69% of the patients became completely seizure-free, and 89% either had no seizures or very rare ones, with very few having complications. Notably, patients who continued to have seizures after surgery had a higher death rate, highlighting that controlling seizures can significantly improve long-term survival. Who this helps: This helps patients with temporal lobe epilepsy considering surgery and their doctors.

Plain English
This study looked at two groups of epilepsy patients to see how well certain brain tests can help locate the source of their seizures. In the first group of 51 patients with clear, one-sided epilepsy, 80% became seizure-free after surgery, and 96% showed specific brain function issues on scans. In contrast, only 44% of the second group of 26 patients achieved the same results, indicating they had more widespread brain problems. Who this helps: This research benefits patients with unitemporal epilepsy who are considering surgery for seizure control.

Plain English
This study looked at how effective gamma knife radiosurgery (GKS) is for treating choroidal melanoma, a type of eye cancer. Eleven patients received this treatment, with a target radiation dose of 40 Gy aimed at shrinking or stopping the tumor’s growth. The results showed that none of the tumors got worse in follow-up periods ranging from 2 to 19 months, and one patient even had improved vision after the treatment. Who this helps: This helps patients diagnosed with small- to medium-sized choroidal melanoma.

Plain English
The study examined 22 patients under 18 years old who had temporal lobe epilepsy (TLE) and underwent surgery. It found that after the surgery, 76% of the patients were seizure-free, while 19% experienced only rare seizures. This research matters because it shows that young patients with TLE can have successful surgical outcomes similar to adults, providing hope for early treatment options. Who this helps: This helps patients with temporal lobe epilepsy and their families.

Plain English
This study tracked 145 patients who underwent surgery for temporal lobe epilepsy between 1984 and 1995 to see how well the treatment worked over time. After about 5.6 years, 55% of the patients were still seizure-free and 85% either had no seizures or very few at their last check-up. The results matter because they show that, overall, surgery for this type of epilepsy has a good long-term success rate, especially for patients with specific brain lesions. Who this helps: This helps patients with temporal lobe epilepsy and their doctors.

Plain English
This study looked at 38 patients with temporal lobe epilepsy who were not helped by medication and were treated surgically. Researchers found that 76% had shrinkage in the hippocampus on MRI scans, while 81.5% showed reduced brain activity in the same area on PET scans. Notably, 90% of the patients became seizure-free or had very few seizures after surgery, indicating that combining these imaging techniques is crucial for better treatment outcomes. Who this helps: Patients with temporal lobe epilepsy and their doctors.

Plain English
This study looked at two imaging tests, ictal SPECT and interictal PET, to see which one better identifies the source of seizures in people with hard-to-treat epilepsy. The researchers found that both tests were similarly effective, with SPECT accurately pinpointing the seizure focus in 27 out of 36 patients and PET in 30 out of 36 patients. This is important because it means these tests can help many patients who are not helped by medications to have surgery that could stop their seizures without needing more invasive procedures. Who this helps: Patients with medically intractable complex partial seizures.

Plain English
This study looked at 98 patients with tough-to-treat temporal lobe epilepsy who had surgery to see what factors predicted a successful outcome. They found that 60% of patients were completely free from seizures after surgery, while 16% had only rare seizures. Key factors linked to better results included a history of febrile seizures, specific brain imaging patterns showing increased blood flow, and certain tissue abnormalities identified during surgery. Who this helps: This information helps patients with epilepsy and their doctors make informed decisions about surgery as a treatment option.

Plain English
This study looked at two cases of a rare brain tumor called pleomorphic xanthoastrocytoma (PXA) in the temporal lobe using MRI scans. The researchers found that the tumors were mostly fluid-filled cysts with a solid part that lit up on the scans, which helps distinguish them from more aggressive tumors like glioblastoma. Recognizing the MRI patterns of this tumor is essential because it has a better outlook than glioblastoma, and correct identification can impact treatment decisions. Who this helps: This helps doctors and patients by improving diagnosis and treatment options for those with brain tumors.

Plain English
This study looked at patients with hereditary amyloidosis who were experiencing spinal claudication, a condition that causes pain due to nerve compression in the spine. Researchers found that spinal canal narrowing was caused by amyloid buildup in the spinal structures, and surgery to relieve this compression was necessary for symptom improvement. Patients who only had part of the spine treated did not see any relief, and their symptoms even got worse. Who this helps: This benefits patients with hereditary amyloidosis and their doctors in diagnosing and treating spinal issues effectively.